Revance Therapeutics Inc.

NASDAQ: RVNC
Share price (1/7/25): $3.41
Market cap (1/7/25): $358 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Tender offer solicitation – amended

Third party tender offer – amended

Tender offer solicitation – amended

Third party tender offer

Tender offer solicitation

Ownership Filter

Hollander David

News Filter

Material Definitive Agreement, Financial Statements or Exhibits

Crown Laboratories and Revance Enter Into Amended and Restated Merger Agreement

Twelfth Waiver to Agreement and Plan of Merger

Eleventh Waiver to Agreement and Plan of Merger

Tenth Waiver to Agreement and Plan of Merger

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

SEC STAFF LETTER

SEC STAFF LETTER